VBC117
/ VelaVigo
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 20, 2026
VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=260 | Not yet recruiting | Sponsor: VelaVigo Bio Inc
First-in-human • New P1/2 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1